Anuh Pharma Limited has informed the Exchange regarding Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And Our Facilities Were Found Compliant Under The Audit.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma's manufacturing facilities at E-17/3, E-17/4 and E-18, MIDC Tarapur (Boisar), Palghar, Maharashtra have successfully cleared the European Directorate for the Quality of Medicines & HealthCare (EDQM) audit. The facilities were found compliant during the inspection. The company states this reaffirms its adherence to global regulatory and quality compliance standards. EDQM certification is important for companies exporting pharmaceutical products to European markets.
Positive for shareholders — EDQM compliance supports the company's ability to supply European markets and strengthens its export credentials, which could support business growth and revenue from regulated markets.